DaVita Inc. (NYSE:DVA) Shares Sold by GHP Investment Advisors Inc.

GHP Investment Advisors Inc. reduced its stake in shares of DaVita Inc. (NYSE:DVA - Free Report) by 4.9% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 41,937 shares of the company's stock after selling 2,146 shares during the quarter. GHP Investment Advisors Inc. owned about 0.05% of DaVita worth $6,415,000 as of its most recent SEC filing.

Other large investors have also recently modified their holdings of the company. UMB Bank n.a. grew its stake in shares of DaVita by 65.5% during the first quarter. UMB Bank n.a. now owns 192 shares of the company's stock valued at $29,000 after buying an additional 76 shares during the last quarter. Copia Wealth Management bought a new position in shares of DaVita during the fourth quarter valued at approximately $30,000. SBI Securities Co. Ltd. bought a new position in shares of DaVita in the 4th quarter worth $41,000. Coppell Advisory Solutions LLC grew its position in shares of DaVita by 50.0% in the 4th quarter. Coppell Advisory Solutions LLC now owns 300 shares of the company's stock worth $45,000 after buying an additional 100 shares during the last quarter. Finally, Canada Post Corp Registered Pension Plan purchased a new stake in DaVita in the fourth quarter valued at about $55,000. Institutional investors own 90.12% of the company's stock.

DaVita Trading Down 0.4%

Shares of NYSE DVA traded down $0.54 during mid-day trading on Wednesday, reaching $140.41. 607,125 shares of the company's stock were exchanged, compared to its average volume of 803,147. The company's 50-day moving average is $139.45 and its 200-day moving average is $149.79. The firm has a market capitalization of $10.60 billion, a price-to-earnings ratio of 13.92, a PEG ratio of 0.94 and a beta of 1.11. DaVita Inc. has a 52-week low of $131.76 and a 52-week high of $179.60. The company has a debt-to-equity ratio of 23.18, a quick ratio of 1.20 and a current ratio of 1.25.

DaVita (NYSE:DVA - Get Free Report) last posted its quarterly earnings results on Monday, May 12th. The company reported $2.00 EPS for the quarter, topping the consensus estimate of $1.75 by $0.25. DaVita had a net margin of 6.63% and a return on equity of 176.11%. The business had revenue of $3.22 billion during the quarter, compared to the consensus estimate of $3.22 billion. During the same quarter in the previous year, the firm posted $2.26 earnings per share. The company's quarterly revenue was up 5.0% compared to the same quarter last year. Analysts expect that DaVita Inc. will post 10.76 EPS for the current fiscal year.

Wall Street Analyst Weigh In

DVA has been the subject of a number of research analyst reports. Truist Financial reduced their target price on DaVita from $170.00 to $164.00 and set a "hold" rating for the company in a research note on Monday, May 19th. Wall Street Zen upgraded DaVita from a "hold" rating to a "buy" rating in a research report on Friday, April 25th. One analyst has rated the stock with a sell rating, four have given a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and an average price target of $164.50.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.